Literature DB >> 11465945

Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice.

I Urbanek-Ruiz1, P J Ruiz, V Paragas, H Garren, L Steinman, C G Fathman.   

Abstract

DNA vaccination is an effective means of protecting experimental animals against infectious pathogens and cancer and has more recently been used to prevent autoimmune disease. Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease characterized by T-cell-mediated destruction of the insulin-secreting beta cells in the pancreas. The NOD mouse is an animal model of IDDM in which several autoantigens, including insulin, have been identified. In this study we demonstrate that vaccination of NOD mice with DNA encoding an immunodominant peptide of insulin (residues 9-23 of the B chain) protects the animals from developing diabetes. Animals injected intramuscularly with a bacterial plasmid encoding the insulin B chain peptide show significantly lower disease incidence and delayed onset of disease when compared to controls. Protection appears to be mediated by insulin B (9-23)-specific down-regulation of IFN-gamma. Our results confirm that DNA vaccination has a protective effect on autoimmunity, the understanding of which will reveal new insights into the immune system and open doors for novel therapies. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465945     DOI: 10.1006/clim.2001.5055

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  10 in total

1.  DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.

Authors:  A Gauvrit; M Debailleul; A-T Vu; P Sai; J-M Bach
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 2.  Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Authors:  Mark C Johnson; Bo Wang; Roland Tisch
Journal:  Hum Vaccin       Date:  2011-01-01

3.  Regulatory cytokine production stimulated by DNA vaccination against an altered form of glutamic acid decarboxylase 65 in nonobese diabetic mice.

Authors:  Yelena Glinka; Renée De Pooter; France Croze; Gérald J Prud'homme
Journal:  J Mol Med (Berl)       Date:  2003-02-11       Impact factor: 4.599

4.  Inducing immune tolerance: a focus on Type 1 diabetes mellitus.

Authors:  Dan Xu; Suchitra Prasad; Stephen D Miller
Journal:  Diabetes Manag (Lond)       Date:  2013-09-01

Review 5.  Antigen-specific therapeutic approaches in Type 1 diabetes.

Authors:  Xavier Clemente-Casares; Sue Tsai; Carol Huang; Pere Santamaria
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

6.  Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection.

Authors:  Georgia Fousteri; Jason R Chan; Yanan Zheng; Chan Whiting; Amy Dave; Damien Bresson; Michael Croft; Matthias von Herrath
Journal:  Diabetes       Date:  2010-09-23       Impact factor: 9.461

7.  Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains.

Authors:  Li Zhang; Jean M Jasinski; Masakazu Kobayashi; Bennett Davenport; Kelly Johnson; Howard Davidson; Maki Nakayama; Kathryn Haskins; George S Eisenbarth
Journal:  J Autoimmun       Date:  2009-03-16       Impact factor: 7.094

Review 8.  Vaccines for multiple sclerosis: progress to date.

Authors:  Jorge Correale; Mauricio Farez; Wendy Gilmore
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes.

Authors:  Jorge Postigo-Fernandez; Rebuma Firdessa-Fite; Rémi J Creusot
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-06       Impact factor: 12.779

Review 10.  Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.

Authors:  Jean-François Bach
Journal:  Arthritis Res       Date:  2002-05-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.